190 related articles for article (PubMed ID: 12211161)
1. Pathogenesis of HIV-associated lipodystrophy.
Wanke C
AIDS Clin Care; 2000 Dec; 12(12):100. PubMed ID: 12211161
[No Abstract] [Full Text] [Related]
2. Buffalo hump: what the experts suggest.
Piliero PJ; McComsey GA
AIDS Clin Care; 2004 Mar; 16(3):22-3. PubMed ID: 15119294
[No Abstract] [Full Text] [Related]
3. Focus on fat.
TreatmentUpdate; 2002 Nov; 14(8):4. PubMed ID: 12501822
[No Abstract] [Full Text] [Related]
4. The latest word on lipodystrophy and mitochondrial toxicity (and old words that still resound).
Mascolini M
IAPAC Mon; 2002 Jan; 8(1):14-32. PubMed ID: 11858198
[No Abstract] [Full Text] [Related]
5. [Antiretroviral treatment for HIV and adipose tissue].
Caron M; Bastard JP; Auclair M; Vigouroux C; Capeau J
Journ Annu Diabetol Hotel Dieu; 2003; ():147-58. PubMed ID: 12868307
[No Abstract] [Full Text] [Related]
6. [Lipodystrophy and 'buffalo hump' during treatment with HIV protease inhibitors].
Dieleman JP; Hillebrand-Haverkort ME; van der Ende ME; Sturkenboom MC; Lange JM; Stricker BH
Ned Tijdschr Geneeskd; 1998 Dec; 142(52):2856-60. PubMed ID: 10065260
[TBL] [Abstract][Full Text] [Related]
7. Lipodystrophy--nukes vs. protease inhibitors.
TreatmentUpdate; 2001 Jul; 13(3):5-6. PubMed ID: 11569989
[No Abstract] [Full Text] [Related]
8. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.
Brinkman K; Smeitink JA; Romijn JA; Reiss P
Lancet; 1999 Sep; 354(9184):1112-5. PubMed ID: 10509516
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro.
Lagathu C; Bastard JP; Auclair M; Maachi M; Kornprobst M; Capeau J; Caron M
Antivir Ther; 2004 Dec; 9(6):911-20. PubMed ID: 15651750
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial DNA levels in fat and blood cells from patients with lipodystrophy or peripheral neuropathy and the effect of 90 days of high-dose coenzyme Q treatment: a randomized, double-blind, placebo-controlled pilot study.
Rabing Christensen E; Stegger M; Jensen-Fangel S; Laursen AL; Ostergaard L
Clin Infect Dis; 2004 Nov; 39(9):1371-9. PubMed ID: 15494915
[TBL] [Abstract][Full Text] [Related]
11. No nukes please.
TreatmentUpdate; 2002 Nov; 14(8):6. PubMed ID: 12501825
[No Abstract] [Full Text] [Related]
12. Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations.
Gougeon ML; Pénicaud L; Fromenty B; Leclercq P; Viard JP; Capeau J
Antivir Ther; 2004 Apr; 9(2):161-77. PubMed ID: 15134178
[TBL] [Abstract][Full Text] [Related]
13. Anti-HIV agents. Leading to lipodystrophy.
TreatmentUpdate; 2007 Feb; 19(2):3-4. PubMed ID: 17447312
[No Abstract] [Full Text] [Related]
14. Drug reactions & lipodystrophy workshop.
Coppedge B
STEP Perspect; 1999; 99(3):17-8. PubMed ID: 11366865
[TBL] [Abstract][Full Text] [Related]
15. Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.
Negredo E; Paredes R; Bonjoch A; Tuldrà A; Fumaz CR; Gel S; Garcés B; Johnston S; Arnó A; Balagué M; Jou A; Tural C; Sirera G; Romeu J; Cruz L; Francia E; Domingo P; Arrizabalaga J; Ruiz I; Arribas JR; Ruiz L; Clotet B
Antivir Ther; 1999; 4 Suppl 3():23-8. PubMed ID: 16021868
[TBL] [Abstract][Full Text] [Related]
16. Lipodystrophy update--the continuing saga.
Proj Inf Perspect; 2001 Mar; (32):9-10. PubMed ID: 11682779
[No Abstract] [Full Text] [Related]
17. Lipodystrophy--introduction.
TreatmentUpdate; 2001; 13(7):2-3. PubMed ID: 11794857
[No Abstract] [Full Text] [Related]
18. Antiretoviral therapy and the lipodystrophy syndrome, part 2: concepts in aetiopathogenesis.
Nolan D; John M; Mallal S
Antivir Ther; 2001 Sep; 6(3):145-60. PubMed ID: 11808750
[TBL] [Abstract][Full Text] [Related]
19. Popping pills for life.
Focus; 1998 Feb; 13(3):5-6. PubMed ID: 11365169
[TBL] [Abstract][Full Text] [Related]
20. HIV-related lipodystrophy: a clinical syndrome with implications for nursing practice.
Lyon DE; Truban E
J Assoc Nurses AIDS Care; 2000; 11(2):36-42; quiz 43-6. PubMed ID: 10752047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
